Physician profile
Mark T Gorsche
NPI 1356789390
$10,090.28
in general payments reported to CMS, 2019-2025
13 companies · $558 in 2025
The $558 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $864 · 2021: $5,804 · 2022: $1,691 · 2023: $510 · 2024: $419 · 2025: $558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,287 · Travel and Lodging: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,286.80 |
| Travel and Lodging | $200.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,647.04 | 2021-2023 | Shoulder Implants Fibertak Knotless |
| Wardlow Enterprises | $2,193.01 | 2020-2022 | |
| Stryker Corporation | $970.18 | 2019-2025 | Mako, Omega, Alphavent |
| Encore Medical, LP | $621.05 | 2024-2025 | Djo Surgical |
| Depuy Synthes Sales INC. | $339.46 | 2019-2024 | Unium, Monovisc, Fibergraft Bg Morsels |
| Wright Medical Technology, INC. | $123.33 | 2019 | |
| Zimmer Biomet Holdings, INC. | $49.43 | 2020-2021 | |
| Convatec INC. | $33.45 | 2021 | |
| Heraeus Medical, LLC. | $32.93 | 2021-2024 | |
| Bioventus LLC | $29.05 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $17.31 | 2019 | |
| Smith+Nephew, INC. | $17.19 | 2023 | Pico 14 |
| Pacira Pharmaceuticals Incorporated | $16.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Gorsche listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.